Munroe
   
 Welcome  
Text Pad Main left last refresh: Print

ATTENTION:  ALL PROVIDERS!!!

 

 

CPOE TRAINING

(based on survey results)

When:

July 6th   – July 24th Hospitalist / Hospitalists and Hospitalist Midlevel’s

July 13th –July 24th  Physicians and Midlevel’s

 

Training Options

1.       eCafe Videos TITLES (Located on the Bulletin Board)http://mrhswss02/Clinical/eCafe/default.aspx)

·         1-Full CPOE (video)

·         2-Admission MedsTracker

·         3-Change Level Care MedsTracker

·         4-Discharge Order

2.       Classroom Training

·         Begins July 13 –24

·         30-minute classes - 4 South Computer Room

Monday - Friday, July 13- 17, 0500-0530, 1200-1230,  18:00-1830

3.       On-Unit Training

·         Schedule with HOO or IPC office

·         Physicians/Provider Mid-levels -  Coordinate Schedule with Brenda Land 402-5228

4.       Training  Booklet with CPOE screen shots and   instructions

·         available in the doctors’  lounges, medical staff office, or call Brenda Land at 402-5228


ACE Inhibitor Substitution

 

Beginning 6/9 the formulary ACE inhibitors will be captopril, enalapril, and lisinopril. Benazpril, moexipril, perindopril, quianpril, ramipril, and trandolopril will be substituted with lisinopril.


Team Notes will no longer be available as of 7/14/15. 

 


Perioperative Bridging Anticoagulation in Atrial Fibrillation

 

The BRIDGE study, a randomized controlled trial, finds no benefit of bridging in reducing the risk of stroke or thromboembolism, but bridging increases bleeding.

(NEJM 2015;DOI:10.1056/NEJMoa1501035)


 


Custom Login last refresh: Print

Text Pad last refresh: Print

REGULATORY CORNER

SGR “Fix” Includes the following:

Medicare Physician Fee Schedule Payments

For July 1, 2015, and ending on December 31, 2019, upward 0.5 percent.

For 2020 and each subsequent year through 2025 shall be 0.0 percent.

Merit-Based Incentive Payment System (MIPS shall apply to payments for items and services furnished on or after January 1, 2019.Section 1848 of the Social Security Act (42 U.S.C. 1395w–4) is amended by adding at the end the following new subsection: (q)

HHS Secretary shall—(i) Develop a methodology for assessing total performance  (ii) Provide a composite performance score and (iii) Use such composite performance score to apply a MIPS adjustment factor to the professional for the year.

Incentive payments for participation in eligible alternative payment models (APM) Section 1833 of the Social Security Act (42 U.S.C. 1395l) is amended by adding at the end the following new subsection: (z)  2019 and 2020, at least 25 percent of payments are furnished by through an eligible alternative payment entity (entity bears more than nominal financial risk if actual aggregate expenditures exceeds expected aggregate expenditures). 2021 and 2022, at least 50 percent of payments. 2023 after at least 75 percent of payments.

   


Text Pad - CM last refresh: Print

Important Information from the Blood Committee

 

A new series of articles will be posted on the Physician Portal to highlight various drugs and their management. One of the drugs highlighted in this article is Apixaban. For the entire article, login to Portal, click on the Home tab and look for the article, "Anticoagulants for Blood Mgmt  Comm NOV 18," a box will pop up giving you an opportunity to Open (to read) or Save/Save As (for future reading).

 

Apixaban (ELIQUIS)

Factor Xa inhibitor

Dose:

For stroke prophylaxis and systemic embolus prevention in non-valvular a. fib:

                For most patients: 5 mg PO BID

                If SCr > 1.5 and age > 80 yr and/or wt < 60 kg: reduce dose to 2.5 mg PO bid

For DVT prophylaxis after knee or hip replacement surgery:

                For all patients: 2.5 mg PO BID x 12 days (knees)

                                                  2.5 mg PO BID x 35 days (hips) 

For DVT or PE treatment:

                10 mg PO BID x 7 days, then 5 mg PO BID for at least 6 months

For reduction in the risk of recurrent DVT and/or PE after completion of treatment for acute DVT or PE:  2.5 mg PO BID

 

Half-life: 9-12 hours

 


Message of the Day last refresh: Print
No content available.


Powered by McKesson HorzionWP Technology